Related Experiment Videos
Using PCR in preimplantation genetic disease diagnosis
1Department of Mathematics, University of Southern California, Los Angeles 90089.
Human Reproduction (Oxford, England)
|July 1, 1991
Summary
Preimplantation genetic diagnosis using PCR has errors. Blastomere analysis is generally more reliable than polar body analysis for detecting genetic diseases, especially when multiple cells are analyzed.
Area of Science:
- Reproductive medicine
- Clinical genetics
- Molecular diagnostics
Background:
- Preimplantation genetic diagnosis (PGD) aids in identifying genetic disorders before embryo implantation.
- In-vitro gene amplification via Polymerase Chain Reaction (PCR) is a key technique in PGD.
- Single-cell PCR analysis is prone to errors, impacting diagnostic accuracy.
Purpose of the Study:
- To analyze the practical consequences and error rates of PGD techniques.
- To compare the diagnostic reliability of embryo biopsy (blastomere analysis) versus polar body analysis.
- To evaluate strategies for minimizing misdiagnosis in PGD.
Main Methods:
- Modeling of diagnostic errors based on experimental PCR error rates (efficiency, cell transfer, contamination).
- Calculation of misdiagnosis probabilities for autosomal dominant and recessive diseases.
- Assessment of combined analysis strategies (multiple blastomeres, polar body + blastomere).
Main Results:
- Blastomere analysis generally yields fewer misdiagnoses than polar body analysis for PGD.
- Exceptions exist for dominant diseases linked to centromeric genes.
- Analyzing multiple blastomeres or combining polar body and blastomere analysis significantly reduces misdiagnosis rates.
Conclusions:
- PGD strategies involving multiple cells enhance diagnostic accuracy.
- Blastomere analysis is often preferred over polar body analysis for PGD reliability.
- Careful consideration of error sources is crucial for successful PGD implementation.